Skip to main content
Top
Published in: Lung 5/2011

01-10-2011

Prevalence of Pulmonary Hypertension in Patients with Idiopathic Pulmonary Fibrosis: Correlation with Physiological Parameters

Authors: D. Papakosta, G. Pitsiou, Z. Daniil, M. Dimadi, E. Stagaki, A. Rapti, K. Antoniou, A. Tzouvelekis, T. Kontakiotis, S. Tryfon, V. Polychronopoulos, D. Bouros

Published in: Lung | Issue 5/2011

Login to get access

Abstract

The aim of this study was to prospectively evaluate the prevalence of pulmonary hypertension (PH) in patients with idiopathic pulmonary fibrosis (IPF). One hundred thirty-nine patients (101 male, mean age = 68.6 ± 9 years), with confirmed IPF and who were admitted to eight Pulmonary Departments in Greece between November 2005 and December 2006 were included in the study. Pulmonary artery systolic pressure (PASP) was estimated by echocardiography, and PH was defined as PASP > 36 mmHg. We compared demographics, pulmonary function tests, NYHA functional status, 6-min walk distance (6MWD), B-type natriuretic peptide (BNP), PaO2, and P(A-a)O2 at rest data between patients with PH and without PH (PASP ≤ 36 mmHg). Increased estimated right ventricular systolic pressure was present in 55% of patients (mean PASP = 47.1 ± 11.2 mmHg vs. 30.3 ± 3.8 mmHg, respectively). Patients with PH had a lower but not statistically significant DLCO (47.1 ± 18.8 vs. 52.5 ± 20.1), lower PaO2 at rest (64.6 ± 12.2 vs. 71.1 ± 11.3, P = 0.004), and lower mean 6MWD (282 ± 118 vs. 338 ± 91, P = 0.007). Significant differences were also observed in the NYHA functional status between the two groups (P = 0.02). Statistically significant correlations were observed between PASP and PaO2 at rest (r = −0.331, P = 0.00), P(A-a)O2 at rest (r = 0.494, P = 0.00), 6MWD (r = −0.264, P = 0.01), SpO2 at rest (r = −0.293, P = 0.00), SpO2 at the end of exercise (r = −0.364, P = 0.00), and also BNP values (r = 0.319, P = 0.01). Moreover, PaO2 (P = 0.02), P(A-a)O2 (P = 0.005), and SpO2 at the end of exercise (P = 0.023) were independent predictors of the presence of estimated PH. Using Doppler echocardiography as a screening tool for the estimation of PH, we found that PH is common in patients with IPF. Gas exchange parameters at rest and exercise desaturation might indicate underlying PH in IPF.
Literature
1.
go back to reference Nathan SD, Noble PW, Tuder RM (2007) Idiopathic pulmonary fibrosis and pulmonary hypertension: connecting the dots. Am J Respir Crit Care Med 175:875–880PubMedCrossRef Nathan SD, Noble PW, Tuder RM (2007) Idiopathic pulmonary fibrosis and pulmonary hypertension: connecting the dots. Am J Respir Crit Care Med 175:875–880PubMedCrossRef
2.
go back to reference King TE Jr, Tooze JA, Schwarz MI, Brown KR, Cherniack RM (2001) Predicting survival in idiopathic pulmonary fibrosis: scoring system and survival model. Am J Respir Crit Care Med 164:1171–1181PubMed King TE Jr, Tooze JA, Schwarz MI, Brown KR, Cherniack RM (2001) Predicting survival in idiopathic pulmonary fibrosis: scoring system and survival model. Am J Respir Crit Care Med 164:1171–1181PubMed
3.
go back to reference Lettieri CJ, Nathan SD, Barnett SD, Ahmad S, Shorr AF (2006) Prevalence and outcomes of pulmonary arterial hypertension in advanced idiopathic pulmonary fibrosis. Chest 129:746–752PubMedCrossRef Lettieri CJ, Nathan SD, Barnett SD, Ahmad S, Shorr AF (2006) Prevalence and outcomes of pulmonary arterial hypertension in advanced idiopathic pulmonary fibrosis. Chest 129:746–752PubMedCrossRef
4.
go back to reference Hamada K, Nagai S, Tanaka S et al (2007) Significance of pulmonary arterial pressure and diffusion capacity of the lung as prognosticator in patients with idiopathic pulmonary fibrosis. Chest 131:650–656PubMedCrossRef Hamada K, Nagai S, Tanaka S et al (2007) Significance of pulmonary arterial pressure and diffusion capacity of the lung as prognosticator in patients with idiopathic pulmonary fibrosis. Chest 131:650–656PubMedCrossRef
5.
go back to reference Song JW, Song JK, Kim DS (2009) Echocardiography and brain natriuretic peptide as prognostic indicators in idiopathic pulmonary fibrosis. Respir Med 103:180–186PubMedCrossRef Song JW, Song JK, Kim DS (2009) Echocardiography and brain natriuretic peptide as prognostic indicators in idiopathic pulmonary fibrosis. Respir Med 103:180–186PubMedCrossRef
6.
go back to reference Nadrous HF, Pellikka PA, Krowka MJ et al (2005) Pulmonary hypertension in patients with idiopathic pulmonary fibrosis. Chest 128:2393–2399PubMedCrossRef Nadrous HF, Pellikka PA, Krowka MJ et al (2005) Pulmonary hypertension in patients with idiopathic pulmonary fibrosis. Chest 128:2393–2399PubMedCrossRef
7.
go back to reference Nathan SD, Shlobin OA, Ahmad S, Urbanek S, Barnett SD (2007) Pulmonary hypertension and pulmonary function testing in idiopathic pulmonary fibrosis. Chest 131:657–663PubMedCrossRef Nathan SD, Shlobin OA, Ahmad S, Urbanek S, Barnett SD (2007) Pulmonary hypertension and pulmonary function testing in idiopathic pulmonary fibrosis. Chest 131:657–663PubMedCrossRef
8.
go back to reference Shorr AF, Wainright JL, Cors CS, Lettieri CJ, Nathan SD (2007) Pulmonary hypertension in patients with pulmonary fibrosis awaiting lung transplant. Eur Respir J 30:715–721PubMedCrossRef Shorr AF, Wainright JL, Cors CS, Lettieri CJ, Nathan SD (2007) Pulmonary hypertension in patients with pulmonary fibrosis awaiting lung transplant. Eur Respir J 30:715–721PubMedCrossRef
9.
go back to reference Nathan SD, Shlobin OA, Ahmad S et al (2008) Serial development of pulmonary hypertension in patients with idiopathic pulmonary fibrosis. Respiration 76:288–294PubMedCrossRef Nathan SD, Shlobin OA, Ahmad S et al (2008) Serial development of pulmonary hypertension in patients with idiopathic pulmonary fibrosis. Respiration 76:288–294PubMedCrossRef
10.
go back to reference Patel NM, Lederer DJ, Borczuk AC, Kawut SM (2007) Pulmonary hypertension in idiopathic pulmonary fibrosis. Chest 132:998–1006PubMedCrossRef Patel NM, Lederer DJ, Borczuk AC, Kawut SM (2007) Pulmonary hypertension in idiopathic pulmonary fibrosis. Chest 132:998–1006PubMedCrossRef
11.
go back to reference Swanson KL, Utz JP, Krowka MJ (2008) Doppler echocardiography—right heart catheterization relationships in patients with idiopathic pulmonary fibrosis and suspected pulmonary hypertension. Med Sci Monit 14:CR177–CR182PubMed Swanson KL, Utz JP, Krowka MJ (2008) Doppler echocardiography—right heart catheterization relationships in patients with idiopathic pulmonary fibrosis and suspected pulmonary hypertension. Med Sci Monit 14:CR177–CR182PubMed
12.
go back to reference American Thoracic Society/European Respiratory Society (2002) ATS/ERS International multidisciplinary consensus classification of the idiopathic interstitial pneumonias. Am J Respir Crit Care Med 165:277–304 American Thoracic Society/European Respiratory Society (2002) ATS/ERS International multidisciplinary consensus classification of the idiopathic interstitial pneumonias. Am J Respir Crit Care Med 165:277–304
13.
go back to reference Miller MR, Hankinson J, Brusasco V, ATS/ERS Task Force et al (2005) Standarization of spirometry. Eur Respir J 26:319–338PubMedCrossRef Miller MR, Hankinson J, Brusasco V, ATS/ERS Task Force et al (2005) Standarization of spirometry. Eur Respir J 26:319–338PubMedCrossRef
14.
go back to reference American Thoracic Society (2002) American Thoracic Society statement: guidelines for the six-minute walk test. Am J Respir Crit Care Med 166:111–117 American Thoracic Society (2002) American Thoracic Society statement: guidelines for the six-minute walk test. Am J Respir Crit Care Med 166:111–117
15.
go back to reference Schiller NB (1991) Two-dimensional echocardiographic determination of left ventricular volume, systolic function and mass. Summary and discussion of the 1989 recommendations of the American Society of Echocardiography. Circulation 83(3 Suppl):1280–1287 Schiller NB (1991) Two-dimensional echocardiographic determination of left ventricular volume, systolic function and mass. Summary and discussion of the 1989 recommendations of the American Society of Echocardiography. Circulation 83(3 Suppl):1280–1287
16.
go back to reference Schiller NB (1990) Pulmonary artery pressure estimation by Doppler and two-dimensional echocardiography. Cardiol Clin 8:277–287PubMed Schiller NB (1990) Pulmonary artery pressure estimation by Doppler and two-dimensional echocardiography. Cardiol Clin 8:277–287PubMed
17.
go back to reference Task Force for Diagnosis and Treatment of Pulmonary Hypertension of ESC/ERS/ISHLT (2009) Guidelines on the diagnosis and treatment of pulmonary hypertension. Eur Respir J 34:1219–1263CrossRef Task Force for Diagnosis and Treatment of Pulmonary Hypertension of ESC/ERS/ISHLT (2009) Guidelines on the diagnosis and treatment of pulmonary hypertension. Eur Respir J 34:1219–1263CrossRef
18.
go back to reference Morrison LK, Harrison A, Krishnaswamy P et al (2002) Utility of a rapid B-natriuretic peptide assay in differentiating congestive heart failure from lung disease in patients presenting with dyspnea. J Am Coll Cardiol 39:202–209PubMedCrossRef Morrison LK, Harrison A, Krishnaswamy P et al (2002) Utility of a rapid B-natriuretic peptide assay in differentiating congestive heart failure from lung disease in patients presenting with dyspnea. J Am Coll Cardiol 39:202–209PubMedCrossRef
19.
go back to reference Flaherty KR, Andrei AC, Murray S et al (2006) Idiopathic pulmonary fibrosis: prognostic value of changes in physiology and six-minute-walk test. Am J Respir Crit Care Med 174:803–809PubMedCrossRef Flaherty KR, Andrei AC, Murray S et al (2006) Idiopathic pulmonary fibrosis: prognostic value of changes in physiology and six-minute-walk test. Am J Respir Crit Care Med 174:803–809PubMedCrossRef
20.
go back to reference Kawut SM, O’Shea MK, Bartels MN, Wilt JS, Sonett JR, Arcasoy SM (2005) Exercise testing determines survival in patients with diffuse parenchymal lung disease evaluated for lung transplantation. Respir Med 99:1431–1439PubMedCrossRef Kawut SM, O’Shea MK, Bartels MN, Wilt JS, Sonett JR, Arcasoy SM (2005) Exercise testing determines survival in patients with diffuse parenchymal lung disease evaluated for lung transplantation. Respir Med 99:1431–1439PubMedCrossRef
21.
go back to reference Gläser S, Noga O, Koch B et al (2009) Impact of pulmonary hypertension on gas exchange and exercise capacity in patients with pulmonary fibrosis. Respir Med 103:317–324PubMedCrossRef Gläser S, Noga O, Koch B et al (2009) Impact of pulmonary hypertension on gas exchange and exercise capacity in patients with pulmonary fibrosis. Respir Med 103:317–324PubMedCrossRef
22.
go back to reference Papadopoulos CE, Pitsiou G, Karamitsos TD et al (2008) Left ventricular diastolic dysfunction in idiopathic pulmonary fibrosis: a tissue Doppler echocardiographic study. Eur Respir J 31:701–706PubMedCrossRef Papadopoulos CE, Pitsiou G, Karamitsos TD et al (2008) Left ventricular diastolic dysfunction in idiopathic pulmonary fibrosis: a tissue Doppler echocardiographic study. Eur Respir J 31:701–706PubMedCrossRef
23.
go back to reference Leuchte HH, Neurohr C, Baumgartner RA et al (2004) Brain natriuretic peptide and exercise capacity in lung fibrosis and pulmonary hypertension. Am J Respir Crit Care Med 170:360–365PubMedCrossRef Leuchte HH, Neurohr C, Baumgartner RA et al (2004) Brain natriuretic peptide and exercise capacity in lung fibrosis and pulmonary hypertension. Am J Respir Crit Care Med 170:360–365PubMedCrossRef
24.
go back to reference Leuchte HH, Baumgartner RA, Nounou ME et al (2006) Brain natriuretic peptide is a prognostic parameter in chronic lung disease. Am J Respir Crit Care Med 173:744–750PubMedCrossRef Leuchte HH, Baumgartner RA, Nounou ME et al (2006) Brain natriuretic peptide is a prognostic parameter in chronic lung disease. Am J Respir Crit Care Med 173:744–750PubMedCrossRef
25.
go back to reference Behr J, Ryu JH (2008) Pulmonary hypertension in interstitial lung disease. Eur Respir J 31:1357–1367PubMedCrossRef Behr J, Ryu JH (2008) Pulmonary hypertension in interstitial lung disease. Eur Respir J 31:1357–1367PubMedCrossRef
26.
go back to reference Nathan SD, Shlobin OA, Barnett SD et al (2008) Right ventricular systolic pressure by echocardiography as a predictor of pulmonary hypertension in idiopathic pulmonary fibrosis. Respir Med 102:1305–1310PubMedCrossRef Nathan SD, Shlobin OA, Barnett SD et al (2008) Right ventricular systolic pressure by echocardiography as a predictor of pulmonary hypertension in idiopathic pulmonary fibrosis. Respir Med 102:1305–1310PubMedCrossRef
27.
go back to reference Zisman DA, Karlamangla AS, Kawut SM et al (2008) Validation of a method to screen for pulmonary hypertension in advanced idiopathic pulmonary fibrosis. Chest 133:640–645PubMedCrossRef Zisman DA, Karlamangla AS, Kawut SM et al (2008) Validation of a method to screen for pulmonary hypertension in advanced idiopathic pulmonary fibrosis. Chest 133:640–645PubMedCrossRef
28.
go back to reference Zhang RF, Zhou L, Ma GF, Shao FC, Wu XH, Ying KJ (2010) Diagnostic value of transthoracic Doppler echocardiography in pulmonary hypertension: a meta-analysis. Am J Hypertens 23:1261–1264PubMedCrossRef Zhang RF, Zhou L, Ma GF, Shao FC, Wu XH, Ying KJ (2010) Diagnostic value of transthoracic Doppler echocardiography in pulmonary hypertension: a meta-analysis. Am J Hypertens 23:1261–1264PubMedCrossRef
29.
go back to reference Fisher MR, Forfia PR, Chamera E et al (2009) Accuracy of Doppler echocardiography in the hemodynamic assessment of pulmonary hypertension. Am J Respir Crit Care Med 179:615–621PubMedCrossRef Fisher MR, Forfia PR, Chamera E et al (2009) Accuracy of Doppler echocardiography in the hemodynamic assessment of pulmonary hypertension. Am J Respir Crit Care Med 179:615–621PubMedCrossRef
Metadata
Title
Prevalence of Pulmonary Hypertension in Patients with Idiopathic Pulmonary Fibrosis: Correlation with Physiological Parameters
Authors
D. Papakosta
G. Pitsiou
Z. Daniil
M. Dimadi
E. Stagaki
A. Rapti
K. Antoniou
A. Tzouvelekis
T. Kontakiotis
S. Tryfon
V. Polychronopoulos
D. Bouros
Publication date
01-10-2011
Publisher
Springer-Verlag
Published in
Lung / Issue 5/2011
Print ISSN: 0341-2040
Electronic ISSN: 1432-1750
DOI
https://doi.org/10.1007/s00408-011-9304-5

Other articles of this Issue 5/2011

Lung 5/2011 Go to the issue
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discuss last year's major advances in heart failure and cardiomyopathies.